Jyothy Laboratories Ltd. said its normalized net income for the fiscal third quarter ended Dec. 31, 2014, was 91 Indian paise per share, compared with the S&P Capital IQ consensus estimate of 2.04 rupees per share.
EPS increased 7.2% year over year from 85 paise.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 165.5 million rupees, a gain of 16.3% from 142.3 million rupees in the year-earlier period.
The normalized profit margin increased to 4.6% from 4.5% in the year-earlier period.
Total revenue grew 13.7% on an annual basis to 3.56 billion rupees from 3.13 billion rupees, and total operating expenses increased 17.5% from the prior-year period to 3.28 billion rupees from 2.79 billion rupees.
Reported net income increased 20.0% from the prior-year period to 264.6 million rupees, or 1.46 rupees per share, from 220.5 million rupees, or 1.32 rupees per share.
As of Jan. 28, US$1 was equivalent to 61.32 Indian rupees.
